Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction was nasal congestion.
The table below shows the adverse reactions that happened during the study.
Adverse reactions
MEDI3250
vaccine Placebo
(Out of 240 (Out of 60
participants) participants)
Nasal congestion 0.8% (2) 0.0% (0)
Bloody nose 0.4% (1) 0.0% (0)
Ear congestion 0.4% (1) 0.0% (0)
Producing extra phlegm 0.4% (1) 0.0% (0)
Rash on arms and hands 0.4% (1) 0.0% (0)
Sneezing 0.4% (1) 0.0% (0)
Stiffness in neck 0.4% (1) 0.0% (0)
Swelling in the throat 0.4% (1) 0.0% (0)
How has this study helped patients and
researchers?
These results helped researchers learn more about the MEDI3250 vaccine and if it
is safe for people to take to prevent them from getting the flu.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with the MEDI3250 vaccine like this one are planned and
will be carried out every year.
7